Introduction
Bisphosphonates, such as alendronate (Fosamax), risedronate (Actonel), ibandronate (Boniva) and zoledronate (Zometa), are important drugs used to treat osteoporosis, Pagets disease, and hypercalcemia due to malignancy. [1] In addition, they have been found to kill tumor cells [2] and activate gd T cells (containing the Vg2Vd2 T cell receptor) to kill tumor cells, and zoledronate has been found to switch tumor-associated macrophages from an M2 (tumor-promoting) phenotype to an M1 (tumor-killing) phenotype. [3] Furthermore, they are active in killing a broad range of protozoan parasites both in vitro [4] and in vivo, [5] and are thus of interest as both anticancer and anti-infective agents. All commercially available bisphosphonate drugs are geminal bisphosphonates and have a common P-C-P backbone (Scheme 1a) together with an R 1 hydroxyl group that increases the affinity of bisphosphonates for bone mineral and is known as the "bone hook". The R 2 group determines the potency of the bisphosphonates, all of which function by inhibiting the enzyme farnesyl diphosphate synthase in osteoclasts. [1] Alendronate (R 1 = OH, R 2 = CH 2 CH 2 CH 2 NH 2 ) is one of the most popular bisphosphonates and has been sold for many years as a treatment for osteoporosis. Bisphosphonates are also known to be good metal-complexing agents, Abstract: We report the synthesis and characterization of five novel Mo-containing polyoxometalate (POM) bisphosphonate complexes with nuclearities ranging from 4 to 12 and with fully reduced, fully oxidized, or mixedvalent (Mo Li 8 
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salts of fully reduced octanuclear and fully oxidized dodecanuclear POMs, respectively. The activities of 2-5 (which are water-soluble) against three human tumor cell lines were investigated in vitro. Although 2-4 have weak but measurable activity, 5 has IC 50 values of about 10 mm, which is about four times the activity of the parent alendro-A C H T U N G T R E N N U N G nate molecule on a per-alendronate basis, which opens up the possibility of developing novel drug leads based on Mo bisphosphonate clusters.
Keywords: antitumor agents · bisphosphonates · molybdenum · O ligands · polyoxometalates and many bisphosphonate compounds, which vary from molecular complexes to three-dimensional coordination frameworks, have been structurally characterized. [6] Among these complexes, polyoxometalates (POMs) are of interest because POMs themselves have interesting medicinal properties, including antitumor and antiretroviral activity, [7] and POM hybrid clusters lead to selective cell adhesion to surfaces. [8] Polyoxometalates are often considered to be soluble molecular oxides. They are built by connecting {MO x } polyhedra, in which M is a d-block element in a high oxidation state, usually V IV,V , Mo VI , or W VI .
[9] Earlier, Sergienko et al. reported the crystallographic structures of the reaction products of Mo VI and W VI ions with bisphosphonates, mainly etidronate. [10] In parallel, Kortz and Pope isolated the poly- [11] as well as the hexanuclear Mo
4À . [12] More recently, Wang et al. described the synthesis of two mixed V IV /Mo VI species, one with etidronate, the other with alendronate. [13] We initiated a study of the reactivity of the reduced dinuclear {Mo )} n (n = 3, 4, 6, 10).
[14] Some of these compounds encapsulated extra ligands, such as carbonate, [14a] sulfite, [14b] or methylarsenate.
[14c]
These anions have been successfully used as both reductants and as stabilizing agents for the synthesis of metallic nanoparticles (Pd 0 , Pt 0 , Ag 0 ), [14c, 15] and we recently extended this family of compounds by using the commercial drug etidronate (R 1 = OH, R 2 = CH 3 ). [16] Of the POMs isolated so far with etidronate, only the one with a cyclohexane-like shape is analogous to those obtained with methylenediphosphonate. The other species that have been isolated are the tetranu-
6À and the tetradecanuclear ring [(Mo
21À . To date, no POMs with bisphosphonate ligands have been studied for activity in cells. We thus decided to explore the reactivity of Mo V and Mo VI ions with more complex bisphosphonates that, on their own, have tumor-cellkilling activity, starting with the commercially used drug alendronate (R 1 = OH, R 2 = (CH 2 ) 3 NH 2 ), [17] with the aim being to see if more potent activity could be obtained. Herein we describe the synthesis and crystallographic and 31 P NMR spectroscopic characterization of four novel POMs containing alendronate (Ale): two with Mo V , one with Mo VI , and an insoluble mixed-valent POM. We also report the synthesis of an aminophenol derivative (MP-Ale) of the alendronate ligand with enhanced binding capacity to transitionmetal ions, and a tetranuclear Mo V compound that incorporates this new ligand. Compounds were then screened for tumor-cell-killing ability in vitro.
Results and Discussion
Crystal structures: In the five crystal structures determined, the 1-hydroxyl group of the bisphosphonate ligand is found to be deprotonated and coordinates to either one or two metal ions (Scheme 2). Valence bond calculations [18] (Figures SI1-SI5 in the Supporting Information) support the proposed oxidation states of Mo in 1-5 and the deprotonation of the hydroxyl groups, and also indicate the presence of terminal water molecules in 3. The anion in 1 (Figure 1a) is built up by connecting three dimeric units, one of which contains two edge-sharing Mo V octahedra and the others are 
6À , except that the etidronate ligands are replaced by Ale or MP-Ale ligands in 2 and 4, respectively. They contain a centrosymmetric rhomboid {Mo V 4 O 16 } core, which is commonly encountered in Mo V chemistry.
[19]
The crystallographically equivalent bisphosphonate ligands act as tetradentate ligands (Scheme 2b) and connect dissymmetrically to the Mo ions. Indeed, one {PO 3 } group is mono-coordinated to a Mo V center, whereas the other phosphonato group is coordinated via two oxygen atoms to an adjacent metallic center. Additionally, the deprotonated hydroxyl group acts as a m 2 -O ligand. In both structures, the counterions are dimethylammonium cations, which establish hydrogen bonds with the POMs (Figures 2b and 3b) . However, these two compounds are not isostructural and their three-dimensional structures are also different. Indeed, the Mo frameworks of the POMs in 2 are parallel, whereas in 4 they are perpendicular, probably because the ligand in 4 is far bulkier than that in 2.
The structure of the octanuclear anion in 3 ( Figure 4a ) has not been observed previously in this family of Mo 
6À in 1. The arrow indicates the position of the symmetry axis. b) 3D structure of 1 with intermolecular hydrogen bonds. Some H atoms have been omitted for clarity. 
4À in 2. b) 3D structure of 2 with intermolecular hydrogen-bonding interactions. Some H atoms have been omitted for clarity. 
6À in 4. b) 3D structure of 4 with intermolecular hydrogen-bonding interactions. Some H atoms have been omitted for clarity. bisphosphonate complexes. It is built up from four Mo V dimers that do not share any oxygen atoms and are only linked by Ale molecules acting as pentadentate ligands (Scheme 2c). One of the Mo V ions is bound to three oxygen atoms of the organic ligand, whereas the other is only bound to two oxygen atoms of Ale and is also connected to a terminal water molecule. The positions of the CH 2 CH 2 CH 2 NH 3 + arms of the organic ligand around the circular Mo framework evoke a paddle-wheel shape. The Mo ions are not coplanar, however, and the wheel is twisted. There are no crystallographic symmetry elements in the structure of 3. However, the anion has a pseudo-S 4 axis passing through the center of the POM framework (Figure 4b) , and in the three-dimensional structure of 3, the anions assemble in centrosymmetric structures and interact through NÀH···O hydrogen bonds (Figure 4c ).
The structure of the anion in 5 (Figure 5a ) can be best described as an assembly of four trimeric units. A trimeric unit is built of a dimer of face-sharing Mo VI octahedra that has a common vertex with a monomeric Mo VI octahedron (Figure 5b) . The Ale ligand acts as a hexadentate ligand with a coordination mode similar to that encountered in 1 (Scheme 2a), together with an additional connection to the monomeric Mo VI ion of a neighboring trimeric group through a terminal oxygen atom of one of the P=O groups (indicated by an arrow in Figure 5b ). Among the six rubidium and two sodium counterions, an octacoordinate sodium ion occupies a special position at the center of the POM, acting as a template ion (as shown in Figure 5a ). Intramolecular N À H···O hydrogen bonds between the amino group of the Ale ligand and terminal or bridging atoms of the POM core stabilize this dodecanuclear architecture (Figures 5c and SI6 in the Supporting Information), and we have recently found evidence for their key role in the intrinsic photochromic properties of these Mo VI species. [20] Although the anion does not lie on any crystallographic symmetry element, a pseudo-S 4 axis can be identified, which passes through the central sodium ion (Figure 5a ), and the three-dimensional structure (Figure 5d ) shows a complex network of polyoxometalate ribbons.
31
P NMR spectroscopic characterization: The synthetic pathways to 1-5 are shown in Scheme 1. We characterized these species in the solid state by single crystal X-ray diffraction (as described above) and in solution by 31 P NMR spectroscopy. As described previously, [14b, 21] 31 P NMR spectroscopy is a powerful tool to determine whether structures characterized in the solid state are maintained in solution, for investigation of the stability of isolated compounds in solution, and for characterizing the nature of the species present in these solutions.
Compound 1 is rather insoluble in all common solvents. Nevertheless, two features can be seen: 1) the 31 P NMR spectrum of a freshly prepared solution of 1 indicates the presence of the octanuclear anion [(Mo
8À , which crystallizes as 3 ( Figure SI7 in the Supporting Information), and 2) the synthetic process that leads to 1 requires slow air oxidation of the reacting solution. 10À species, which contains two Mo VI centers.
[14b] The 31 P NMR spectra of freshly prepared synthetic solutions of 2 and 4 ( Figure SI8 in the Supporting Information) are similar to those of crystals of 2 and 4 in water ( Figure 6 ). These spectra exhibit a doublet of doublets, in agreement with the presence of two nonequivalent and coupled phosphorus atoms within the bisphosphonate ligand. No change is observed over a period of one week, that is, 2 and 4 are stable in pure aqueous solutions. The chemical shifts and coupling constants of 2 and 4 are very similar, and are also similar to those of the etidronate derivative [(Mo
6À [16] ( Table 1) .
In contrast, the 31 P NMR spectrum of 2 in the presence of Li + changes rapidly with time: a solution of 2 in 1 m LiCl (Figure 7 and SI9 in the Supporting Information) indicates degradation of 2 into three species. Slow evaporation of a solution of 2 in 1 m LiCl afforded crystals of 3, and comparison of the 31 P NMR spectrum of 3 redissolved in water with that of a solution of 2 in 1 m LiCl permits identification of 3 as one of the three species. The other two are unknown. The 31 P NMR spectrum of 3 ( Figure 6 ) also exhibits a doublet of doublets (as with 2 and 4), but the splitting between the two doublets is smaller and the coupling constant is larger. As expected and similar to 2, compound 4 degrades slowly in 1 m LiCl. Compound 5 is sparingly soluble in water but dissolves readily in 1 m NaOAc/AcOH buffer and 1 m NaCl. As for 2-4, the 31 P NMR spectrum of 5 ( Figure 6 ) exhibits a doublet of doublets, in accord with the presence of two nonequivalent phosphorus atoms. Moreover, solutions of 5 are stable over a period of at least one week.
A C H T U N G T R E N N U N G [(Mo 2 O 4 ) 3 (O 3 PCH 2 PO 3 ) 3 A C H T U N G T R E N N U N G (CH
Cell-growth inhibition: To determine whether 1-5 have activity in the inhibition of tumor-cell growth, we screened all compounds against three tumor cell lines: NCI-H460 (human nonsmall lung cancer); MCF-7 (human breast cancer), and SF-268 (human CNS cancer). Compound 1 was poorly soluble and no inhibition activity was found, but 2-5 all had measurable activity ( Table 2 ). For compounds 2-4 the activity was worse than that of alendronate, especially on a per-alendronate basis. However, 5 was clearly more active than alendronate. Averaged over the three cell lines, alendronate had an IC 50 of about 160 mm, whereas that of 5 was about 10 mm, or about 40 mm on a per-alendronate basis, a fourfold increase in potency. Whether this enhanced activity is due to dissociation of the complex outside the cell (and uptake of alendronate and a molybdate), to dissociation inside the cell, or to POM-complex activity per se (as with, e.g., Mo 7 O 24 2À[7c] ) is unknown at this time. However, the comparison of the activity of 2-5 with that of commercial (NH 4 ) 6 Mo VI 7 O 24 and of [22] which do not contain any bisphosphonate ligands, suggests that the POM and the alendronate ligand have a synergic effect. In conclusion, the observation that bisphosphonate activity is enhanced is of interest, and suggests that more lipophilic bisphosphonate [2] POM complexes may have much better activity.
Conclusion
Hybrid bisphosphonate POM complexes built by condensing Mo octahedra and bisphosphonate ligands with nuclearities from 4 to 12, either fully reduced, mixed-valent, or fully oxidized, have been isolated, and show the strong chelating ability of this class of ligand. As observed with previously reported Mo bisphosphonate complexes, the geometry of the POM is strongly dependent on the nature of the ligand and counterion. Although most bisphosphonate POM compounds reported in the literature are insoluble, the Mo VI and Mo V complexes reported here are soluble and stable in aqueous solution, with the exception of 1, as evidenced by 31 P NMR spectroscopy. Our results thus open the way to the synthesis of a large family of functionalized Mo bisphosphonates in which the nature of the organic ligand is varied. It may thus be possible to obtain hybrid POM bisphosphonates containing redox-active POMs that have potent antitumor activity and potent bisphosphonates all packed in a lipophilic complex, which would increase cell uptake and bisphosphonate potency. Further work on such systems is underway.
Experimental Section
Chemicals and reagents: Alendronic acid, H 2 O 3 PC-A C H T U N G T R E N N U N G (C 3 H 6 NH 2 )(OH)PO 3 H 2 (H 4 Ale), was synthesized as described in the literature. [23] All other chemicals were used as purchased without further purification. The synthetic pathways to the aminophenol derivative of Ale (MP-Ale) and to 1-5 are given in Scheme 1.
Preparation of [Mo 2 O 4 A C H T U N G T R E N N U N G (H 2 O) 6 ]
2 + in aqueous HCl: Hydrazine hydrate N 2 H 4 ·H 2 O (210 mL, 4.29 mmol) was added to a suspension of MoO 3 (2.30 g, 16.0 mmol) in aqueous HCl (4 m, 80 mL). The mixture was then stirred at 60 8C for 3 h and the resulting deep red solution (0.1 m) was allowed to cool to RT before further use.
Synthesis of Na 2 HO 3 PCA C H T U N G T R E N N U N G (C 10 H 14 NO)(OH)PO 3 H·2 H 2 O [Na 2 H 2 A C H T U N G T R E N N U N G (MP-Ale)]:
H 4 Ale (5 g, 20 mmol) and salicylaldehyde (2.5 mL, 24 mmol) were dissolved in a mixture of methanol (100 mL) and triethylamine (17 mL, 120 mmol). The deep orange solution was heated to reflux for two hours, and then cooled to RT before portionwise addition of sodium borohydride (1.14 g, 30 mmol). The resulting yellow suspension was heated to reflux overnight, and then the pale yellow solid was collected by filtration under vacuum, thoroughly washed with methanol, and dried with diethyl ether (yield 73 %, 5.9 g). 
2 + (0.1 m, 6.25 mL, 0.625 mmol) synthesized as described above. Aqueous ammonium hydroxide (33 %, 1.8 mL, 15 mmol) was then added dropwise to pH 7.3. The resulting deep red solution was filtered, and then left to evaporate at RT. After 2 d, large red parallelepipedic crystals were collected by filtration (0. (0.1 m, 6.25 mL, 0.625 mmol) prepared as described above. Diethylamine (2.8 mL, 27 mmol) was added dropwise to pH 6.8. The resulting deep red solution was filtered and left to evaporate at RT. Small, red, parallelepipedic crystals were collected by filtration the following day (0.211 g, 48 % based on Mo). X-ray crystallography: Data collection was carried out by using a Siemens SMART three-circle diffractometer for all structures except 4 and 5, for which data were collected by using a Bruker Nonius X8 APEX 2 diffractometer. Both were equipped with a CCD bidimensional detector using the monochromatized wavelength lA C H T U N G T R E N N U N G (Mo Ka ) = 0.71073 . Data were collected at RT for 1-3 and 5, and at 100 K for 4 because these crystals were unstable due to loss of water of hydration. Absorption corrections were based on multiple and symmetry-equivalent reflections in the data set by using the SADABS program, [24] based on the method of Blessing. [25] Structures were solved by direct methods, and refined by fullmatrix least-squares methods by using the SHELXTL package. [26] In all structures there is a discrepancy between the formulae determined by elemental analysis and that deduced from the crystallographic atom list because of the difficulty in locating all the disordered water molecules and alkali metal counterions. Disordered water molecules and alkali metal counterions were thus refined with partial occupancy factors and with isotropic thermal parameters. In the structure of 1, NH 4 + and H 2 O could not be distinguished based on the observed electron densities; therefore, all positions were labeled as O and assigned the oxygen atomic diffusion factor. Crystallographic data are given in Table 3. CCDC 779541 (1), 779542 (2), 779543 (3), 779544 (4), and 779545 (5) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Synthesis of [(C
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Synthesis of Na
2 Rb 6 A C H T U N G T R E N N U N G [(Mo VI 3 O 8 ) 4 A C H T U N G T R E N N U N G (O 3 PCA C H T U N G T R E N N U N G (
NMR measurements:
31 P NMR spectra were recorded in 5 mm tubes with 1 H decoupling by using a Bruker AC-300 spectrometer operating at 121.5 MHz.
31
P chemical shifts were referenced to the external standard of 85 % H 3 PO 4 . For all compounds, % 20 mg of sample was dissolved in D 2 O (700 mL), except for 5, which was dissolved in 700 mL of a mixture of D 2 O (10 %) and NaOAc/AcOH buffer (90 %, 1 m). The concentrations thus varied between 2-8 mm. For the kinetic study, compound 2 (20 mg, 1.34 10 À5 mol) was dissolved in LiCl (600 mL, 1 m, pH 3.7) solution to which 100 mL of D 2 O was added.
Infrared spectra: IR spectra were recorded by using an IRFT Magna 550 Nicolet spectrophotometer on KBr pellets.
Cell growth inhibition assays: Human tumor cell lines MCF-7 (breast adenocarcinoma), NCI-H460 (lung large cell), and SF-268 (central nervous system glioblastoma) were obtained from the National Cancer Institute and maintained at 100 % humidity and 5 % CO 2 at 37 8C. Cell lines were cultured in RPMI-1640 medium supplemented with 2 mm l-glutamine and 10 % fetal bovine serum (Gibco, Grand Island, NY) at 37 8C in a 5% CO 2 atmosphere with 100 % humidity. Compound stock solutions were typically prepared in water at a concentration of 0.04 m. A broth microdilution method was used to determine the growth inhibition IC 50 values of the bisphosphonates. Compounds were half-log serially diluted with cell culture media into 96-well tissue-culture (TC)-treated round-bottom plates (Corning, Corning, NY), typically from 1264 mm to 40 nm, but in Table 3 . Crystallographic data for 1-5. 
